{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Time+Management&page=9", "query": { "intervention": "Time Management", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 4334, "total_pages": 434, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Time+Management&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Time+Management&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T11:01:57.330Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01008319", "title": "Traditional Clomiphene Citrate Administration vs. Stair-step Approach", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ovulatory Dysfunction", "Anovulation", "Ovulation Induction" ], "interventions": [ { "name": "clomiphene citrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 120, "start_date": "2009-10", "completion_date": "2015-11", "has_results": true, "last_update_posted_date": "2018-01-08", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT01008319" }, { "nct_id": "NCT02251912", "title": "Oxytocin Treatment of Alcohol Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol Dependence" ], "interventions": [ { "name": "Intranasal Oxytocin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 22, "start_date": "2015-07", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2017-08-15", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02251912" }, { "nct_id": "NCT00731367", "title": "Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Split-Thickness Donor Sites." ], "interventions": [ { "name": "Aquacel Ag Gelled", "type": "DEVICE" }, { "name": "Aquacel Ag Adherent", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "ConvaTec Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 73, "start_date": "2005-10", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2009-02-03", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00731367" }, { "nct_id": "NCT01277692", "title": "A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "GSK2336805 10mg", "type": "DRUG" }, { "name": "GSK2336805 30mg", "type": "DRUG" }, { "name": "GSK2236805 100mg", "type": "DRUG" }, { "name": "GSK2236805 200mg", "type": "DRUG" }, { "name": "GSK2236805 10mg", "type": "DRUG" }, { "name": "GSK2236805 dose to be determined up to 100mg", "type": "DRUG" }, { "name": "GSK2236805 5mg", "type": "DRUG" }, { "name": "GSK2236805 30mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 58, "start_date": "2010-11-03", "completion_date": "2011-05-09", "has_results": false, "last_update_posted_date": "2017-06-28", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 3, "location_summary": "Chula Vista, California • Lenexa, Kansas • Willingboro, New Jersey", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Willingboro", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01277692" }, { "nct_id": "NCT05400122", "title": "Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colorectal Cancer", "Hematologic Malignancy", "Rectum Cancer", "Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Acute Lymphoblastic Leukemia", "Chronic Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Hodgkin Lymphoma", "Non Hodgkin Lymphoma", "Myeloproliferative Syndrome", "Plasma Cell Myeloma", "Gastric Cancer", "Esophageal Cancer", "Esophagus Cancer", "Gastric Cancer, Metastatic", "Unresectable Esophageal Cancer", "Metastatic Esophageal Cancer" ], "interventions": [ { "name": "Vactosertib", "type": "DRUG" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "IL-2", "type": "DRUG" }, { "name": "Natural Killer Cells", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David Wald", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2022-09-09", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05400122" }, { "nct_id": "NCT05415202", "title": "Remimazolam Sedation for Nerve Blocks", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Procedural Anxiety", "Procedural Pain" ], "interventions": [ { "name": "Remimazolam 20 MG [Byfavo]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2022-06-06", "completion_date": "2022-08-01", "has_results": false, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05415202" }, { "nct_id": "NCT07890337", "title": "Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Traumatic Brain Injuries", "TBI (Traumatic Brain Injury)", "MTBI - Mild Traumatic Brain Injury", "mTBI", "Traumatic Brain Injury | Patient", "Traumatic Brain Injury and Co-occurring Disorders", "PTSD - Post Traumatic Stress Disorder" ], "interventions": [ { "name": "Virtual Reality", "type": "DEVICE" }, { "name": "Standard Psychotherapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 30, "start_date": "2026-10", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07890337" }, { "nct_id": "NCT04160065", "title": "Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Merkel Cell Carcinoma", "Cutaneous Squamous Cell Carcinoma", "Non-Melanoma Skin Cancers" ], "interventions": [ { "name": "IFx-Hu2.0", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "TuHURA Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2020-03-03", "completion_date": "2024-08-13", "has_results": false, "last_update_posted_date": "2024-09-23", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 4, "location_summary": "Los Angeles, California • Tampa, Florida • Boston, Massachusetts + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04160065" }, { "nct_id": "NCT04740229", "title": "Moderate-intensity Flow-based Yoga Effects on Cognition and Stress", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress", "Psychological" ], "interventions": [ { "name": "Yoga", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Illinois at Urbana-Champaign", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 86, "start_date": "2021-02-10", "completion_date": "2021-08-30", "has_results": false, "last_update_posted_date": "2022-06-06", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 1, "location_summary": "Urbana, Illinois", "locations": [ { "city": "Urbana", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04740229" }, { "nct_id": "NCT05915377", "title": "Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Delirium", "Delirium in Old Age", "Delirium With Dementia", "Delirium Superimposed on Dementia" ], "interventions": [ { "name": "READI-SET GO UB-CAM delirium screening into EHR", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Penn State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "70 Years", "maximum_age": null, "sex": "ALL", "summary": "70 Years and older" }, "enrollment_count": 1050, "start_date": "2024-04-03", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-02-20", "last_synced_at": "2026-10-23T11:01:57.330Z", "location_count": 2, "location_summary": "Boston, Massachusetts • State College, Pennsylvania", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "State College", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05915377" } ] }